Skip to content

    Recently Viewed



      What you need to know about Johnson & Johnson’s 2022 first-quarter earnings

      Check out this infographic breakdown of the company’s first-quarter 2022 performance, with key highlights from its Pharmaceutical, MedTech and Consumer Health businesses.

      Share Article
      share to

      This morning, Johnson & Johnson shared its first-quarter performance.

      Since its founding in 1886, the company has grown to become one of the world’s largest and most broadly based healthcare companies, with approximately 144,000 employees across the globe working every day to help change the trajectory of health for humanity.

      “Even in the face of some macro-economic headwinds, Johnson & Johnson posted strong results for the quarter, continuing to deliver reliable growth and investing to advance our pipeline. We’re proud to announce a dividend increase for the 60th consecutive year, a key capital allocation priority. We remain well positioned to accelerate innovation as we evolve into a smarter era of healthcare, and work to successfully stand up the New Consumer Health Company,” says Joe Wolk, Executive Vice President and Chief Financial Officer, Johnson & Johnson.

      For more details about the company’s 2022 first-quarter results, and to read a message from Chief Executive Officer Joaquin Duato, here’s an infographic that highlights key stats.

      An infographic showing key stats about Johnson & Johnson's first-quarter 2022 earnings

      Want to see more company earnings information? Find Johnson & Johnson’s past quarterly and full-year results here.

      More from Johnson & Johnson

      DNA illustration genetic material

      Harnessing the human genome is the future of healthcare—and Johnson & Johnson is helping lead the way

      The company’s partnership with the largest human genome sequencing project in the world will increase scientists’ understanding of genetic diseases and help create new interventions. Here, a look at the breakthroughs that have guided the understanding of the power of DNA.
      Health & wellness
      1123 BTN-Lung Cancer-Iede2.jpg
      Health & wellness

      By the numbers: Who gets lung cancer?

      Each year, more people die of lung cancer than colon, breast and prostate cancers combined. Learn how Johnson & Johnson is dedicated to improving outcomes by integrating the company’s MedTech and Innovative Medicine expertise.
      Health & wellness
      Health & wellness

      Quiz: How much do you know about psoriasis?

      The chronic skin condition causes itchy and scaly patches, but it’s much more than simply a cosmetic concern. For World Psoriasis Day, take this quiz to test your psoriasis IQ—and learn why Johnson & Johnson is working on new and more effective treatments for this common autoimmune disease.
      You are now leaving and going to a site with a different privacy policy. Please click below to continue to that site.